Doomsdays for Valeant, Biogen and biotech VC | File Type: audio/mpeg | Duration: 21:50
Doomsdays for Valeant, Biogen and biotech VC
Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand | File Type: audio/mpeg | Duration: 28:55
Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand
Biotech's Wall Street malaise, Valeant's Washington woes, and immuno-oncology's primetime slot | File Type: audio/mpeg | Duration: 26:30
Biotech's Wall Street malaise, Valeant's Washington woes, and immuno-oncology's primetime slot
Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud | File Type: audio/mpeg | Duration: 21:43
Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud
John Carroll on Turing Pharma and Martin Shkreli | File Type: audio/mpeg | Duration: 14:58
John Carroll on Turing Pharma and Martin Shkreli
Lilly and Boehringer's 'amazing' diabetes data, biotech's VC boom, and Severin Schwan's hot mic | File Type: audio/mpeg | Duration: 28:23
Lilly and Boehringer's 'amazing' diabetes data, biotech's VC boom, and Severin Schwan's hot mic
GlaxoSmithKline's horrible, no good, very bad year; Kyle Bass' 'truthful irrelevancy'; and the return of vanity pharma websites | File Type: audio/mpeg | Duration: 26:36
GlaxoSmithKline's horrible, no good, very bad year; Kyle Bass' 'truthful irrelevancy'; and the return of vanity pharma websites
Valeant's fantasy football M&A, the gathering PCSK9 storm, and Novartis' alarming new campaign | File Type: audio/mpeg | Duration: 28:13
Valeant's fantasy football M&A, the gathering PCSK9 storm, and Novartis' alarming new campaign
The future of 'female Viagra,' the return of Allergan buyout chatter, and an overuse of the word 'allegedly' | File Type: audio/mpeg | Duration: 28:55
The future of 'female Viagra,' the return of Allergan buyout chatter, and an overuse of the word 'allegedly'
Amarin's First Amendment crusade, Martin Shkreli's Twitter and Kim Kardashian's Instagram | File Type: audio/mpeg | Duration: 31:55
Amarin's First Amendment crusade, Martin Shkreli's Twitter and Kim Kardashian's Instagram
Shire's $30B gambit, Merck's '100% effective' Ebola vaccine, and GSK's latest corruption scandal | File Type: audio/mpeg | Duration: 29:11
Shire's $30B gambit, Merck's '100% effective' Ebola vaccine, and GSK's latest corruption scandal
Allergan's 'transformational' moves, Sanofi's new bet on Regeneron, and the (latest) biggest-ever biotech IPO | File Type: audio/mpeg | Duration: 25:15
Allergan's 'transformational' moves, Sanofi's new bet on Regeneron, and the (latest) biggest-ever biotech IPO
Lilly and Biogen at #AAIC2015, the first PCSK9 approval, and selling drugs to millennials | File Type: audio/mpeg | Duration: 28:39
Lilly and Biogen at #AAIC2015, the first PCSK9 approval, and selling drugs to millennials
Celgene's $7.2B splash, Sanofi's shakeup, and GSK's big, bad wolf | File Type: audio/mpeg | Duration: 23:21
Celgene's $7.2B splash, Sanofi's shakeup, and GSK's big, bad wolf
Novartis and Vertex score big approvals, Mylan runs into real estate controversy, and @brentlsaunders makes a splash on Twitter | File Type: audio/mpeg | Duration: 21:00
Novartis and Vertex score big approvals, Mylan runs into real estate controversy, and @brentlsaunders makes a splash on Twitter
